强耀生物科技
强耀生物
强耀生物
强耀生物科技version: English | 中文版
强耀生物科技
强耀生物科技
在线客服 
强耀生物科技
强耀生物科技
微信平台
强耀生物科技
手机网站

服务
产品强耀生物科技
强耀生物
您的位置:首页>> 产品 >> 常用产品

强耀生物科技 Exendin-4
名称 Exendin-4
别名 Exendin4exenatide; Byetta
序列(单字母缩写) HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-NH2
序列(三字母缩写) {HIS}{GLY}{GLU}{GLY}{THR}{PHE}{THR}{SER}{ASP}{LEU}{SER}{LYS}{GLN}{MET}{GLU}{GLU}{GLU}{ALA}{VAL}{ARG}{LEU}{PHE}{ILE}{GLU}{TRP}{LEU}{LYS}{ASN}{GLY}{GLY}{PRO}{SER}{SER}{GLY}{ALA}{PRO}{PRO}{PRO}{SER}-NH2
C-端 NH2
基本描述 Exendin-4 is a 39-amino acid peptide amide. Exendin-4, like Exendin-3, stimulates an increase in acinar cAMP without stimulating the release of amylase. Exendin-4 is a long-acting potent agonist of the glucagon-like peptide 1 (GLP-1). Exendin-4 is the active component of Byetta (exenatide) injection, which may improve glycemic control in people with type 2 diabetes mellitus and has the potential to reduce plasma glucose at least partly by a delay in gastric emptying as well as by reducing calorie intake. Exendin-4 enhances glucose-dependent insulin secretion by the pancreatic β-cell and suppresses inappropriately elevated glucagon secretion.
溶解度 Soluble in water. The contents of this vial have been accurately determined. Both the stopper and the vial have been siliconized. Do not attempt to weigh out a smaller portion of the contents.
分子量 4186.660
化学式 C184H282N50O60S
纯度 > 95%
存储条件 Store the peptide at -20°C.
注释 This peptide interacts interacts with exendin receptor to increase pancreatic acinar cAMP. It has no secretagogue activity and does not bind to VIP receptors.
Documents 文档
Figures
Reference Gardiner SM, et al. Mesenteric vasoconstriction and hindquarters vasodilatation accompany the pressor actions of exendin-4 in conscious rats. J. Pharmacol. Exp. Ther. Feb 2006; 316(2): 852-859. Park S, et al. Exendin-4 uses Irs2 signaling to mediate pancreatic beta cell growth and function. J. Biol. Chem. Jan 2006; 281(2): 1159-1168. Kim MJ, et al. Exendin-4 induction of cyclin D1 expression in INS-1 beta-cells: involvement of cAMP-responsive element. J. Endocrinol. Mar 2006; 188(3): 623-633. Jain R., etc. Pharmacological inhibition of Eph receptors enhances glucose-stimulated insulin secretion from mouse and human pancreatic islets. Diabetologia. 2013 Jun;56(6):1350-1355. Shiraishi D., etc. Glucagon-Like Peptide-1 (Glp-1) Induces M2 Polarization Of Human Macrophages Via Stat3 Activation. Biochem Biophys Res Commun. 2012 Aug;425(2):304 - 8. Wei Gao and William J. Jusko.., etc. Pharmacokinetic and Pharmacodynamic Modeling of Exendin-4 in Type 2 Diabetic Goto-Kakizaki Rats. J Pharmacol Exp Ther. 2011 Mar;336(3):881 - 890.


联系我们    |    人才招聘    |    关于我们    |    公司帐户   
联系电话:021-50795728 联系邮箱 inside@Chinapeptides.com
上海强耀生物科技有限公司 版权所有  沪ICP备16000238号